Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $1.815B (100.0% shares, 0.0% debt)

Holdings (42)

STAA STAAR SURGICAL CO 10.7%
Value $193M Shares 1,267,811 Est. Cost $14.28 Unrealized +822.6%
BMRN BIOMARIN PHARMACEUTICAL INC 10.2%
Value $185M Shares 2,212,950 Est. Cost $83.16 Unrealized -4.7%
ABIOMED INC 10.0%
Value $182M Shares 583,933 Est. Cost $81.43 Unrealized
INSM INSMED INC 9.4%
Value $171M Shares 6,019,106 Est. Cost $17.79 Unrealized +66.8%
BIIB BIOGEN INC 6.9%
Value $125M Shares 361,600 Est. Cost $264.51 Unrealized +14.5%
UTHR UNITED THERAPEUTICS CORP 6.8%
Value $123M Shares 687,206 Est. Cost $89.23 Unrealized +113.4%
FOLD AMICUS THERAPEUTICS INC 5.3%
Value $96.42M Shares 10,002,443 Est. Cost $9.51 Unrealized +2.6%
REVANCE THERAPEUTICS INC 5.2%
Value $94.9M Shares 3,201,866 Est. Cost $24.09 Unrealized
PRTA PROTHENA CORP PLC 4.9%
Value $89.02M Shares 1,731,482 Est. Cost $21.46 Unrealized +45.4%
VNDA VANDA PHARMACEUTICALS INC 4.5%
Value $81.56M Shares 3,791,805 Est. Cost $11.21 Unrealized +59.6%
EHTH EHEALTH INC 3.7%
Value $66.92M Shares 1,145,870 Est. Cost $71.48 Unrealized -8.0%
ACAD ACADIA PHARMACEUTICALS INC 3.1%
Value $57.02M Shares 2,337,877 Est. Cost $33.89 Unrealized -33.4%
EPIZYME INC 3.1%
Value $56.98M Shares 6,856,513 Est. Cost $14.39 Unrealized
KARYOPHARM THERAPEUTICS INC 3.1%
Value $55.55M Shares 5,383,052 Est. Cost $16.78 Unrealized
SAGE THERAPEUTICS INC 1.9%
Value $34.11M Shares 600,500 Est. Cost $49.38 Unrealized
ALGN ALIGN TECHNOLOGY INC 1.9%
Value $33.85M Shares 55,405 Est. Cost $114.31 Unrealized +417.7%
CLOVIS ONCOLOGY INC 1.4%
Value $26.01M Shares 4,484,411 Est. Cost $47.56 Unrealized
GRITSTONE ONCOLOGY INC 1.2%
Value $21.51M Shares 2,356,282 Est. Cost $9.42 Unrealized
ALEXION PHARMACEUTICALS INC 1.0%
Value $17.43M Shares 94,850 Est. Cost $124.52 Unrealized
GOSS GOSSAMER BIO INC 0.8%
Value $14.4M Shares 1,772,950 Est. Cost $11.85 Unrealized -26.8%
PBYI PUMA BIOTECHNOLOGY INC 0.7%
Value $12.79M Shares 1,392,997 Est. Cost $27.70 Unrealized -63.4%
DICERNA PHARMACEUTICALS INC 0.7%
Value $12.42M Shares 332,713 Est. Cost $5.39 Unrealized
ALKS ALKERMES PLC 0.7%
Value $11.94M Shares 487,100 Est. Cost $19.79 Unrealized +12.4%
ANAB ANAPTYSBIO INC 0.6%
Value $11.32M Shares 436,592 Est. Cost $19.06 Unrealized +25.8%
SNDX SYNDAX PHARMACEUTICALS INC 0.4%
Value $6.887M Shares 401,100 Est. Cost $16.23 Unrealized +12.9%
KLDO KALEIDO BIOSCIENCES INC 0.3%
Value $5.851M Shares 786,400 Est. Cost $13.76 Unrealized -48.5%
MAGENTA THERAPEUTICS INC 0.2%
Value $4.228M Shares 432,300 Est. Cost $7.38 Unrealized
ZOGENIX INC 0.2%
Value $3.71M Shares 214,700 Est. Cost $20.95 Unrealized
KEZAR LIFE SCIENCES INC 0.2%
Value $3.563M Shares 656,200 Est. Cost $5.16 Unrealized
RIGEL PHARMACEUTICALS INC 0.2%
Value $2.831M Shares 652,395 Est. Cost $3.40 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value $2.448M Shares 123,686 Est. Cost $6.71 Unrealized +249.8%
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value $2.423M Shares 166,069 Est. Cost $23.56 Unrealized -16.3%
ALIMERA SCIENCES INC 0.1%
Value $1.828M Shares 200,919 Est. Cost $6.30 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $1.822M Shares 160,800 Est. Cost $7.10 Unrealized +69.4%
ATHENEX INC 0.1%
Value $1.47M Shares 318,200 Est. Cost $12.86 Unrealized
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.1%
Value $1.409M Shares 27,100 Est. Cost $39.74 Unrealized +36.0%
MARINUS PHARMACEUTICALS INC 0.0%
Value $562K Shares 31,330 Est. Cost $15.48 Unrealized
SYROS PHARMACEUTICALS INC 0.0%
Value $439K Shares 80,600 Est. Cost $7.48 Unrealized
VIRACTA THERAPEUTICS INC 0.0%
Value $377K Shares 33,212 Est. Cost $9.24 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value $374K Shares 24,500 Est. Cost $27.01 Unrealized -33.1%
IDERA PHARMACEUTICALS INC 0.0%
Value $92,000 Shares 77,044 Est. Cost $8.90 Unrealized
MINERVA NEUROSCIENCES INC 0.0%
Value $84,000 Shares 36,319 Est. Cost $5.62 Unrealized